World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
156
Citations
92349
World Ranking
918
National Ranking
521

Research.com Recognitions

  • 2014 - Fellow, National Academy of Inventors
  • 2012 - Fellow of the American Academy of Arts and Sciences
  • 2004 - Distinguished Scientist Award, American Heart Association
  • 1998 - Member of the National Academy of Medicine (NAM)
  • Member of the European Academy of Sciences and Arts
  • Member of the Association of American Physicians
  • Member of the European Academy of Sciences and Arts
  • Member of the Association of American Physicians

Overview

Victor J. Dzau is affiliated with Duke University in the United States and has made substantial contributions to medical research, primarily within the fields of Medicine, Biochemistry, Genetics, and Molecular Biology. Their work spans several subfields, including Molecular Biology, General Health Professions, Public Health, Environmental and Occupational Health, Surgery, and Infectious Diseases.

Dzau's research interests cover key topics such as Pluripotent Stem Cells Research, Health and Medical Research Impacts, Healthcare cost, quality, and practices, CRISPR and Genetic Engineering, Tissue Engineering and Regenerative Medicine, RNA Interference and Gene Delivery, and Primary Care and Health Outcomes.

They have published extensively in notable venues. The most frequent publication venues include:

  • JAMA
  • The Lancet
  • Circulation
  • NAM Perspectives
  • New England Journal of Medicine

Selected recent papers authored or co-authored by Victor J. Dzau include:

  • "Digital technology and COVID-19" (2020, Nature Medicine)
  • "Preventing a Parallel Pandemic - A National Strategy to Protect Clinicians' Well-Being" (2020, New England Journal of Medicine)
  • "Access to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politics" (2020, The Lancet)
  • "Basic and Translational Research in Cardiac Repair and Regeneration" (2021, Journal of the American College of Cardiology)
  • "The Imperative for Diversity and Inclusion in Clinical Trials and Health Research Participation" (2022, JAMA)

Frequent co-authors associated with Dzau include:

  • Conrad P. Hodgkinson
  • Richard E. Pratt
  • Syeda S. Baksh
  • Hualing Sun
  • Melissa H. Laitner

Throughout their career, Dzau has been recognized with various awards and honors. These include membership in the National Academy of Medicine since 1998, fellowship of the American Academy of Arts and Sciences since 2012, fellowship of the National Academy of Inventors awarded in 2014, as well as distinctions from professional bodies such as the American Heart Association and membership in the European Academy of Sciences and Arts and the Association of American Physicians.

Best Publications

  • The Emerging Concept of Vascular Remodeling

    Gary H. Gibbons;Victor J. Dzau

  • Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy

    Massimiliano Gnecchi;Zhiping Zhang;Aiguo Ni;Victor J. Dzau

  • Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts

    Abeel A Mangi;Nicolas Noiseux;Deling Kong;Huamei He

  • Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells

    Massimiliano Gnecchi;Massimiliano Gnecchi;Huamei He;Olin D Liang;Luis G Melo;Luis G Melo;Luis G Melo

  • Digital technology and COVID-19.

    Daniel Shu Wei Ting;Lawrence Carin;Victor Dzau;Victor Dzau;Tien Y. Wong

  • Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement

    Massimiliano Gnecchi;Huamei He;Nicolas Noiseux;Olin D. Liang

  • Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

    Mark A. Creager;John P. Cooke;Michael E. Mendelsohn;Shelly J. Gallagher

  • Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies

    Victor J. Dzau;Ruediger C. Braun-Dullaeus;Daniel G. Sedding

  • The heart in hypertension.

    Edward D. Frohlich;Carl Apstein;Aram V. Chobanian;Richard B. Devereux

  • Tissue Angiotensin and Pathobiology of Vascular Disease A Unifying Hypothesis

    Victor J. Dzau

  • L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.

    Mark A. Creager;Shelly J. Gallagher;Xavier J. Girerd;Sharon M. Coleman

  • Angiotensin II type 2 receptor mediates programmed cell death

    Takehiko Yamada;Masatsugu Horiuchi;Victor J. Dzau

  • Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat.

    Howard J. Jacob;Howard J. Jacob;Klaus Lindpaintner;Klaus Lindpaintner;Stephen E. Lincoln;Kenro Kusumi

  • MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes

    Tilanthi M. Jayawardena;Bakytbek Egemnazarov;Elizabeth A. Finch;Lunan Zhang

  • The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer

    Masatoshi Nakajima;Howard G. Hutchinson;Masahiko Fujinaga;Wataru Hayashida

  • Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene

    H. E. Von Der Leyen;G. H. Gibbons;R. Morishita;N. P. Lewis

  • Nitric oxide synthase: role in the genesis of vascular disease.

    John P. Cooke;Victor J. Dzau

  • Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

    G H Gibbons;R E Pratt;V J Dzau

  • Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.

    A J Naftilan;R E Pratt;V J Dzau

  • Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice

    Lutz Hein;Gregory S. Barsh;Gregory S. Barsh;Richard E. Pratt;Victor J. Dzau

Frequent Co-Authors

Masatsugu Horiuchi
Masatsugu Horiuchi Ehime University
Ryuichi Morishita
Ryuichi Morishita Osaka University
John P. Cooke
John P. Cooke Houston Methodist
Yasufumi Kaneda
Yasufumi Kaneda Osaka University
Julie R. Ingelfinger
Julie R. Ingelfinger Harvard University
Mark A. Creager
Mark A. Creager Dartmouth College
Alan T. Hirsch
Alan T. Hirsch University of Minnesota
Edgar Haber
Edgar Haber Harvard University
Howard J. Jacob
Howard J. Jacob AbbVie (United States)
Martin Paul
Martin Paul Ruhr University Bochum

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees opens up flexible and rewarding career options beyond studying traditional Medicine in the USA. For those interested in the administrative side, healthcare administration degrees are available online, providing skills to manage healthcare facilities and lead teams with a focus on efficiency and patient care.

If you prefer a clinical path, consider starting with an Associate Degree in Nursing and progressing through adn to fnp bridge programs, allowing registered nurses to become Family Nurse Practitioners while studying online.

Entry barriers are decreasing thanks to options like nursing school no entrance exam pathways. These let students avoid traditional standardized entrance tests, making it easier to start their nursing education—and career.

For those drawn to health information management, online medical coding classes with financial aid provide affordable and accessible training, supporting career fast-tracks in essential medical billing and coding roles.

Best Scientists Citing Victor J. Dzau

Trending Scientists